HUM Humana Inc.

PQA Presents CarePlus Health Plans with its Excellence in Quality Award

, Florida’s largest* 5 out of 5-star Medicare Advantage plan, has been recognized by the (PQA) with its Excellence in Quality award for exemplary management of medications for its members. CarePlus is a subsidiary of Humana Inc. (NYSE: HUM).

PQA provides two awards, an Excellence in Quality Award and a Quality Improvement Award, which are based on published Centers for Medicare & Medicaid Services (CMS) Medicare Part D Star Ratings. CarePlus is one of only five in the nation to receive the organization’s top recognition in 2021.

“We are incredibly proud to once again be recognized by PQA with this Excellence in Quality Award,” said CarePlus President Bruno Piquin. “It not only speaks to the hard work and dedication that our team puts into serving our 185,000 members in Florida, but it also is due to the quality of health care that our value-based physician partners provide to our members.”

The Excellence in Quality Award recognizes Medicare Advantage Prescription Drug (MAPD) plans and Prescription Drug Plans (PDPs). MAPDs are recognized for achieving at least a 4.5-star Part D summary rating and a 5-star rating on all five PQA medication measures used in the 2021 CMS Star Ratings program.

Five PQA-endorsed quality measures are used in the 2021 Medicare Part D Star Ratings program, and several others are used as Display measures. Details on these measures are available at . CMS evaluates Medicare plans based on a 5-star rating system. Star Ratings are calculated each year and may change from one year to the next. More information about Star Ratings can be found at .

About CarePlus Health Plans

CarePlus Health Plans, Inc. is dedicated to improving the lives of Medicare beneficiaries in Florida. We provide affordable, reliable healthcare and prescription drug coverage that helps our members maintain and improve their health so they can enjoy happy, active, and independent lives.

CarePlus offers Medicare Advantage Prescription Drug Plans with comprehensive benefits designed to meet a variety of needs. We partner with and support our physicians, pharmacists, dentists, and other healthcare providers who we trust to take good care of our community. Through our partnership with the ACCESS Florida Department of Children and Families, CarePlus Health Plans, Inc.’s Social Services department assists members to apply for public assistance through a variety of state and federal programs. This assistance and guidance is completely voluntary and offered at no additional cost.

CarePlus has supported Florida residents with their Medicare options for over 20 years. Based in Florida, with corporate offices in Miami and Tampa, we serve more than 185,000* members across South and North Florida, the Tampa, Orlando and Daytona areas, and the Space Coast.

For more information, visit .

Every year, Medicare evaluates plans based on a 5-star rating system.

*According to the Centers for Medicare & Medicaid Services (CMS) Medicare Advantage (MA) Membership Reports, May 2021.

H1019_PRPQAExcellenceinQAAward2021_C

EN
02/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Humana Inc.

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 17, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Humana Inc: 1 director

Two Directors at Humana Inc bought 7,133 shares at between 0.000USD and 229.247USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch